Genesis Global Group
Home
Patents

Breaking new ground.

US

  1. Antibodies Specific to Antigens of Bartonella henselae and Use of These Antigens in Immunoassays. McCool, T., Chang Loa, C., Adelson, M.E., Mordechai, E., US Patent Number 7,727,711. Issued on 6/1/2010

  2. Compositions and Methods for Detecting Atopobium vaginae. Trama, J., Adelson, M.E., Mordechai, E., US Patent Number 7,745,595. Issued on 6/29/2010

  3. Method for Determining Azole Resistance in Candida glabrata. Gygax, S., Vermitsky, J.P., Self, M., Adelson, M.E., Mordechai, E., US Patent Number 8,021,846. Issued on 9/20/2011

  4. Compositions and Methods for Detecting Borrelia afzeli. Feola, M., Adelson, M.E., Mordechai, E., Novak, L., US Patent Number 8,026,056. Issued on 9/27/2011

  5. Compositions and Methods for Detecting Cryptococcus neoformans. Feola, M., Adelson, M.E., Mordechai, E., US Patent Number 7,989,186. Issued on 10/2/2011

  6. Methods and Compositions Related Thereto for Detecting and Indentifying Distinct Species of Nucleic Acids from Causative Agent. Adelson, M.E., Feola, M., Trama, J., Mordechai, E., US Patent Number 8,030,032. Issued on 10/4/2011

  7. Antibodies Specific to Antigens of Bartonella henselae and Use of These Antigens in Immunoassays. McCool, T., Chang Loa, C., Adelson, M.E., Mordechai, E., US Patent Number 8,101,367. Issued on 1/24/2012

  8. Babesia microti Genomic Clones Containing Novel Antigens Useful in the Diagnosis of Babesiosis. Hoey, J., Venit, H., Adelson, M.E., Mordechai, E., Valois-Cruz, F., US Patent Number 8,388,981. Issued on 5/15/2012

  9. Splice Variants of Human IL-23 Receptor (IL-23R) mRNA and Use of a Delta 9 Isoform in Predicting Inflammatory Bowel Diseases. Gallagher, G.,Yu, R., Kan, S., Mancini, G., US Patent Number 8,206,925. Issued on 6/26/2012

  10. Compositions and Methods for Detecting Borrelia afzeli. Feola, M., Adelson, M.E., Mordechai, E., Novak, L., US Patent Number 8,206,930. Issued on 6/26/2012

  11. Protein Fragments of virB10 and Sero-Detection of Anaplasma Phagocytophilum. Hoey, J., Dimitrov, D., Huang, L., Adelson, M.E., Mordechai, E., US Patent Number 8,389,678. Issued on 7/19/2012

  12. Detection of Penicillin Tolerance in Group B Streptococcus: Single Nucleotide Polymorphisms in Penicillin Binding Protein 4. Gygax, S., Prasa, A., Adelson, M.E., Mordechai, E., US Patent Number 8,247,170. Issued on 8/21/2012

  13. Hemolysin and its Protein Fragments in Sero-detection of Anaplasma phagocytophilum. Hoey, J., Dimitrov, D., Huang, L., Adelson, M.E., Mordechai, E., US Patent Number 8,257,938. Issued on 9/4/2012

  14. Protein Fragments of virB10 and Sero-Detection of Anaplasma Phagocytophilum. Hoey, J. Dimitrov, D., Huang, L., Adelson, M.E., Mordechai, E., US Patent Number 8,283,130. Issued on 9/9/2012

  15. Ex-vivo Treatment of Peripheral Blood Leukocytes with IFN-Lambda. Gallagher, G., Megjugorac, N., Gallagher, G.E., US Patent Number 8,282,964. Issued on 9/9/2012

  16. Novel Recombinant 15-kDa Polypeptide and Use of Same in Detecting Human Infection with Bartonella henselae. Hoey, J., Venit, H., Adelson, M.E., Mordechai, E., Valois-Cruz, F., US Patent Number 8,268,569. Issued on 9/18/2012

  17. Babesia microti Genomic Clones Containing Novel Antigens Useful in the Diagnosis of Babesiosis. Hoey, J., Venit, H., Adelson, M.E., Mordechai, E., Valois-Cruz, F., US Patent Number 8,178,310. Issued on 10/9/2012

  18. Type IV Secretion System Proteins in Sero-Detection of Anaplasma phagocytophilum. Hoey, J. Dimitrov, D., Huang, L., Adelson, M.E., Mordechai, E., US Patent Number 8,323,907. Issued on 12/4/2012

  19. Type IV Secretion System Proteins in Sero-Detection of Anaplasma phagocytophilum. Hoey, J., Dimitrov, D., Huang, L., Adelson, M.E., Mordechai, E., US Patent Number 8,338,190. Issued on 12/25/2012

  20. A Novel Repressor on IFN-l Promoter and siRNA Against ZEB1 and BLIMP-1 to Increase IFN-l Gene Activity. Gallagher, G., Siegel, R., Eskdale, J., US Patent Number 8,349,808. Issued on 1/8/2013

  21. Ex-vivo Treatment of Peripheral Blood Leukocytes with IFN-Lambda. Gallagher, G., Eskdale, J., Srinivas, S., Dai, J., Megjugorac, N., Gallagher, G.E., US Patent Number 8,354,125. Issued on 1/15/2013

  22. Compositions and Methods for Detecting Cryptococcus neoformans. Feola, M., Adelson, M.E., Mordechai, E., Entwistle, J., US Patent Number 8,377,656. Issued on 2/19/2013

  23. Methods and Compositions for Detecting Serotypes of Chlamydia trachomatis Capable of Causing Lymphogranuloma Venereum. Feola, M., Trama, J., Mordechai, E., Adelson, M.E., US Patent Number 8,394,936. Issued on 3/12/2013

  24. Single Nucleotide Polymorphisms as Genetic Markers for Childhood Leukemia. Dorak, M.T., Ucisik-Akkaya, E., Davis, C., Ngoc Do., T., US Patent Number 8,394,587. Issued on 3/12/2013

  25. Splice Variants of Human IL-23 Receptor (IL-23R) mRNA and Use of a Delta 9 Isoform in Predicting Inflammatory Bowel Diseases. Gallagher, G.,Yu, R., Kan, S., Mancini, G., US Patent Number 8,404,824. Issued on 3/26/2013

  26. Anaplasma Translocated Protein-1 (ATS-1) and Sero-Detection of Anaplasma phagocytophilum. Hoey, J., Dimitrov, D., US Patent Number 8,455,211. Issued on 6/4/2013

  27. Methods and Compositions for Detecting and Identifying Species of Candida. Trama, J., Adelson, M.E., Mordechai, E., US Patent Number 8,501,408. Issued on 8/6/2013

  28. A Detection Kit Containing A Novel Recombinant 15-kDA Polypeptide Useful For Detecting Human Infection with Bartonella Henselae. Hoey, J., Venit, H., Adelson, M.E., Mordechai, E., Valois-Cruz, F., US Patent Number 8,580,271. Issued on 11/12/2013

  29. Recombinant Fragments and Synthetic Peptides of 17-kDa Polypeptide Useful in Detecting Bartonella henselae. Huang, L., Hoey, J., Adelson, M.E., Mordechai, E., US Patent Number 8,283,439. Issued on 11/12/2013

  30. Anti-sense Oligonucleotides Targeted Against Exon 9 of IL-23 R alpha Gene and Method of Using Same to Induce Exon Skipping and to Treat Inflammatory Bowel Diseases. Gallagher, G., Yu, R., Brazaitis, J., US Patent Number 8,618,070. Issued on 12/13/2013

  31. DEK as a Urine Based Biomarker for Bladder Cancer. Datta, A., Trama, J., US Patent Number 8,658,376. Issued on 2/25/2014

  32. Method of Determining Types I, II, III, IV or V of Methicillin-resistant Staphylococcus aureus (MRSA) in a Biological Sample. Gygax, S., Overmeyer, C., DeSalvia, L., Adelson, M., Eli Mordechai, E., US Patent Number 8,715,936. Issued on 5/6/2014

  33. Detection of a Specific DEK Isoform as a Urine-Based Biomarker for Bladder Cancer. Antara Datta, A., Trama, J., US Patent Number 8,741,582. Issued on 6/3/2014

  34. METRONIDAZOLE RESISTANCE IN TRICHOMONAS VAGINALIS AND SINGLE NUCLEOTIDE POLYMORPHISMS. Hilbert, D., Gygax, S., Adelson, M., Mordechai, E., Schuyler, J., Paulish-Miller, T., US Patent Number 8,741,563. Issued on 6/3/2014

  35. Ex-vivo Treatment of Peripheral Blood Leukocytes with IFN-Lambda. Gallagher, G., Gallagher, J., Dai, J., Megjugorac, N., Gallagher, G., US Patent Number 8,771,666. Issued on 7/8/2014

  36. A Method of Determining Susceptibility of a Tumor Cell to a Chemotherapeutic Agent: Novel Use of Herpes Simplex Virus. Blaho, J., US Patent Number 8,778,331. Issued on 7/15/2014

  37. A Novel Repressor on IFN-Lambda Promoter and siRNA Against ZEB1 and BLIMP-1 to Increase IFN-Lambda Gene Activity. Eskdale, J., Gallagher, G., Siegel, R., US Patent Number 8,802,648. Issued on 8/12/2014

  38. Hemolysin and its Protein Fragments in Sero-detection of Anaplasma phagocytophilum. Hoey, J., Dimitrov, D., Huang, L., Adelson, M., Mordechai, E., US Patent Number 8,859,722. Issued on 10/14/2014

  39. CIP2A as a Biomarker in Detection of Cervical Cancer. Huang, L., Trama, J., US Patent Number 8,900,813. Issued on 12/2/2014

  40. Methods and Compositions Related Thereto for Detecting and Identifying Distinct Species of Nucleic Acids from Causative Agents. Adelson, M., Feola, M., Trama, J., Mordechai, E., US Patent Number 8,932,832. Issued on 1/13/2015

  41. A Novel Repressor on IFN-Lambda Promoter and siRNA Against ZEB1 and BLIMP-1 to Increase IFN-Lambda Gene Activity. Gallagher, G., Siegel, R., Eskdale, J., Swider, A., US Patent Number 8,933,049. Issued on 1/13/2015

  42. Novel Polypeptides that Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof. Gallagher, G., Yu, R., Brazais, J., US Patent Number 8,946,150. Issued on 2/3/2015

  43. Methods and Compositions for Detecting Serotypes of Chlamydia trachomatis Capable of Causing Lymphogranuloma Venereum. Trama, J., Mordechai, E., Adelson, M., US Patent Number 8,956,814. Issued on 2/17/2015

  44. Detecting DNA Methylation of BCL2, CDKN2A and NID2 Genes to Predict Bladder Cancer in Humans. Scher, M.,Trama, J., US Patent Number 9,096,905. Issued on 8/4/2015

  45. Anaplasma Translocated Protein-1 (ATS-1) and Sero-Detection of Anaplasma phagocytophilum. Dimitrov, D., Hoey, J., US Patent Number 9,134,324. Issued on 9/15/2015

  46. SiRNA Targeting ETS1 and ELK1 and Method of Using Same in the Inhibition of CIP2A Gene in Cancer Treatment. Rice, L., Pallai, R., US Patent Number 9,139,829. Issued on 9/22/2015

  47. Oligonucleotides Useful in Methods for Detecting and Characterizing Aspergillus fumigatus. Trama, J., Adelson, M., Mordechai, E., US Patent Number 9,145,593. Issued on 9/29/2015

  48. A Novel Repressor on IFN-l Promoter and siRNA Against ZEB1 and BLIMP-1 to Increase IFN-l Gene Activity. Gallagher, G., Siegel, R., Eskdale, J., US Patent Number 9,163,238. Issued on 10/20/2015

  49. Novel Polypeptides that Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof. Gallagher, G., Yu, R., Brazaitis, J., US Patent Number 9,169,292. Issued on 10/27/2015

  50. Anti-sense Oligonucleotides Targeted Against Exon 9 of IL-23 R alpha Gene and Method of Using Same to Induce Exon Skipping and to Treat Inflammatory Bowel Diseases. Gallagher, G., Yu, R., Brazaitis, J., US Patent Number 9,187,750. Issued on 11/17/2015

  51. Novel Haplotype Tagging Single Nucleotide Polymorphisms and Use of Same to Predict Childhood Lymphblastic Leukemia. Florence Davis, C., Tevfik Dorak, M., US Patent Number 9,212,395. Issued on 12/15/2015

  52. A Method of Enhancing MIR-185 Expression to Reduce Low Density Lipoprotein/Cholesterol Accumulation in a Cell. Yang, M., Nickels, J., Liu, W, Ann Pellicane, C., US Patent Number 9,243,250. Issued on 1/26/2016

  53. ELISA Detection of Urine DEK to Predict and Diagnose Bladder Cancer in Humans. Datta, A., Trama, J., US Patent Number 9,255,925. Issued on 2/9/2016

  54. Methods and Compositions for Detecting and Identifying Species of Candida. Trama, J., Adelson, M., Mordechai, E., US Patent Number 9,267,170. Issued on 2/23/2016

  55. Antibiotic Resistance Profile for Neisseria gonorrhoeae and Use of Same in Diagnosis and Treatment of Gonorrhea. Balashov, S., Mordechai, E., Adelson, M., US Patent Number 9,297,048. Issued on 3/29/2016

  56. Methods and Reagents that Specifically Detect, Distinguish and Quantify IFN-λ2 mRNA from IFN-λ3 mRNA in Humans. Gallagher, G., Gallagher, G. E., Eskdale, J., Siegel, R., US Patent Number 9,464,321. Issued on 10/11/2016

  57. Integrated Method for Collection and Maintenance of Detectability of a Plurality of Microbiological Agents in a Single Clinical Sample and for Handling a Plurality of Samples For Reportong a Sum of Diagnostic Results for Each Sample. Adelson, M., Mordechai, E., US Patent Number 9,464,310. Issued on 10/11/2016

  58. A Novel Repressor on IFN-l Promoter and siRNA Against CRX, GATA1 and EVI1 to Alter IFN-l Gene Activity. Gallagher, G., Siegel, R., Eskdale, J., US Patent Number 9,506,066. Issued on 11/29/2016

  59. ELISA for Naturally-occurring Soluble Truncated Forms of IL-23 Receptor. Gallagher, G., Yu, R., Eskdale, J., Branzaitis, J., US Patent Number 00. Issued on 12/20/2016

  60. Metronidazole Resistance in Trichomonas Vaginalis and Single Nucleotide Polymorphism. Hilbert, D., Gygax, S., Adelson, M., Mordechai, E., Schuyler, J., Paulish-Miller, T., US Patent Number 9,593,384. Issued on 3/14/2017

  61. Novel Polypeptides that Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof. Gallagher, G., Yu, R., Branzaitis, J., US Patent Number 9,605,027. Issued on 3/28/2017

  62. PME-1 as a Biomarker to Predict and Diagnose Endometrial Cancer and Gene Silencing of PME-1 to Inhibit Epithelial to Mesenchymal Transition. Rice, L., Pusey, M., Wandzioch, E., Marie Genevieve Bail, S., Lynn Werda, A., US Patent Number 9,657,349. Issued on 5/23/2017

International

  1. Babesia microti Genomic Clones Containing Novel Antigens Useful in the Diagnosis of Babesiosis.. Hoey, J., Venit, H., Adelson, M., Mordechai, E., Valois-Cruz, F., Filed 6/11/2009. Application No. PCT/US2009/046975

  2. Novel Recombinant 15-kDa Polypeptide and use of same in Detecting Human Infection with Bartonella henselae. Hoey, J., Huang, L., Adelson, M., Mordechai, E., Filed 8/6/2009. Application No. PCT/US2009/052921

  3. Recombinant Fragments and Synthetic Peptides of 17-kDa Polypeptide Useful in Detecting Bartonella henselae. Huang, L., Hoey, J., Adelson, M., Mordechai, E., Filed 8/6/2009. Application No. PCT/US2009/052948; EP 2326660

Notice

This link leads to the machine-readable files that are made available to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine readable files are formatted to allow researchers, regulators and application developers to more easily access and analyze data.

Cancel Continue